{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T11:41:34Z","timestamp":1704368494821},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","emed.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Emergency Medicine Clinics of North America"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.emc.2014.07.014","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T08:29:12Z","timestamp":1410856152000},"page":"835-849","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Emergency Department Antimicrobial Considerations in Severe Sepsis"],"prefix":"10.1016","volume":"32","author":[{"given":"Robert S.","family":"Green","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean K.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.emc.2014.07.014_bib1","unstructured":"Centers for Disease Control and Prevention. National Hospital Ambulatory Medical Care Survey: 2010 Emergency Department summary tables. Available at: http:\/\/www.cdc.gov\/nchs\/data\/ahcd\/nhamcs_emergency\/2010_ed_web_tables.pdf. Accessed October 15, 2013."},{"key":"10.1016\/j.emc.2014.07.014_bib2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.annemergmed.2006.05.003","article-title":"National study of emergency department visits for sepsis, 1992 to 2001","volume":"48","author":"Strehlow","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2014.07.014_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/CCM.0b013e3181cb0cdc","article-title":"The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis","volume":"38","author":"Levy","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/519283","article-title":"A\u00a0systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients","volume":"45","author":"McGregor","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.emc.2014.07.014_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.emc.2014.07.014_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11908-011-0203-y","article-title":"Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock","volume":"13","author":"Taccone","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.emc.2014.07.014_bib8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.emc.2014.07.014_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jemermed.2010.10.024","article-title":"Effective antibiotic treatment prescribed by emergency physicians in patients admitted to the intensive care unit with severe sepsis or septic shock: where is the gap?","volume":"41","author":"Capp","year":"2011","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.emc.2014.07.014_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1017\/S148180350001054X","article-title":"Canadian Association of Emergency Physicians sepsis guidelines: the optimal management of severe sepsis in Canadian emergency departments","volume":"10","author":"Green","year":"2008","journal-title":"CJEM"},{"issue":"Suppl","key":"10.1016\/j.emc.2014.07.014_bib12","first-page":"1","article-title":"Optimizing initial antibiotic delivery for adult patients with severe sepsis and septic shock in the emergency department","author":"Green","year":"2012","journal-title":"EM Critical Care"},{"key":"10.1016\/j.emc.2014.07.014_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4065\/mcp.2010.0639","article-title":"General principles of antimicrobial therapy","volume":"86","author":"Leekha","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.emc.2014.07.014_bib14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jama.1995.03530120060042","article-title":"Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units","volume":"274","author":"Brun-Buisson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.emc.2014.07.014_bib15","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/CCM.0b013e31821b85f4","article-title":"Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis","volume":"39","author":"Johnson","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib16","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.emc.2014.07.014_bib17","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ajic.2012.01.017","article-title":"Positive clinical risk factors predict a high rate of methicillin-resistant Staphylococcus aureus colonization in emergency department patients","volume":"40","author":"Wakatake","year":"2012","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.emc.2014.07.014_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"Niederman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","article-title":"Extended-spectrum \u03b2-lactamase-producing organisms","volume":"73","author":"Falagas","year":"2009","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.emc.2014.07.014_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/1742-6723.12100","article-title":"Timing of appropriate antibiotics in patients with septic shock: a retrospective cohort study","volume":"25","author":"Cullen","year":"2013","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.emc.2014.07.014_bib21","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1097\/CCM.0b013e31821e87ab","article-title":"Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol","volume":"39","author":"Puskarich","year":"2011","journal-title":"Crit Care Med"},{"issue":"Suppl 11","key":"10.1016\/j.emc.2014.07.014_bib22","doi-asserted-by":"crossref","first-page":"S513","DOI":"10.1097\/01.CCM.0000143119.41916.5D","article-title":"Source control in the management of severe sepsis and septic shock: an evidence-based review","volume":"32","author":"Marshall","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib23","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00134-012-2695-9","article-title":"Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT international cohort study","volume":"38","author":"Tabah","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijantimicag.2008.03.015","article-title":"Pharmacokinetics\/pharmacodynamics of antibacterials in the intensive care unit: setting appropriate dosing regimens","volume":"32","author":"Scaglione","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.emc.2014.07.014_bib25","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1097\/CCM.0b013e318180fe62","article-title":"Antibiotic resistance \u2013 what\u2019s dosing got to do with it?","volume":"36","author":"Roberts","year":"2008","journal-title":"Crit Care Med"},{"issue":"S3","key":"10.1016\/j.emc.2014.07.014_bib26","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0924-8579(09)70552-7","article-title":"Early antibiotic treatment failure","volume":"34","author":"Sanchez Garcia","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.emc.2014.07.014_bib27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2011.12","article-title":"Antibiotic dosing in critically ill patients with acute kidney injury","volume":"7","author":"Eyler","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.emc.2014.07.014_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ccc.2010.09.006","article-title":"Pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock","volume":"27","author":"Varghese","year":"2011","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.emc.2014.07.014_bib29","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.CCM.0000277043.85378.C1","article-title":"National estimates of severe sepsis in United Stated emergency departments","volume":"35","author":"Wang","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib30","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1345\/aph.1P251","article-title":"Assessing the effect of the Surviving Sepsis Campaign treatment guidelines on clinical outcomes in a community hospital","volume":"44","author":"Patel","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"10 Suppl 2","key":"10.1016\/j.emc.2014.07.014_bib31","first-page":"S525","article-title":"Optimizing antimicrobial therapy and emerging pathogens","volume":"4","author":"Nicolau","year":"1998","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.emc.2014.07.014_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/00003088-200342090-00002","article-title":"Selecting antibacterials for outpatient parenteral antimicrobial therapy: pharmacokinetic-pharmacodynamic considerations","volume":"42","author":"Slavik","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.emc.2014.07.014_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/381972","article-title":"Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections","volume":"38","author":"Pankey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.emc.2014.07.014_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.idc.2004.04.012","article-title":"Pharmacodynamics of antimicrobial drugs","volume":"18","author":"Levison","year":"2004","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.emc.2014.07.014_bib35","first-page":"1811","article-title":"Aminoglycosides: a practical review","volume":"15","author":"Gonzalez","year":"1998","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.emc.2014.07.014_bib36","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc9091","article-title":"Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.emc.2014.07.014_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/cid\/cis856","article-title":"Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial","volume":"56","author":"Dulhunty","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.emc.2014.07.014_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cid\/cis857","article-title":"Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin\/tazobactam: a systematic review and meta-analysis","volume":"56","author":"Falagas","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.emc.2014.07.014_bib39","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc8945","article-title":"Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.emc.2014.07.014_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijantimicag.2011.03.022","article-title":"Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity","volume":"38","author":"Galvez","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.emc.2014.07.014_bib41","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/AAC.42.7.1842","article-title":"Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by Gram-negative organisms","volume":"42","author":"Kashuba","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.emc.2014.07.014_bib42","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2125.2011.04005.x","article-title":"Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal","volume":"72","author":"Garot","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.emc.2014.07.014_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jac\/dkp139","article-title":"Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution","volume":"64","author":"Roberts","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.emc.2014.07.014_bib44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2009.10.008","article-title":"First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis","volume":"35","author":"Roberts","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.emc.2014.07.014_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijantimicag.2005.04.005","article-title":"Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis","volume":"26","author":"Gous","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.emc.2014.07.014_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5414\/CPP44262","article-title":"Do intensive care patients need an individualized dosing regimen for levofloxacin?","volume":"44","author":"Tayab","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.emc.2014.07.014_bib47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.emc.2014.07.014_bib48","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1378\/chest.10-2371","article-title":"Antibiotic dosing in multiple organ dysfunction syndrome","volume":"139","author":"Ulldemonlins","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.emc.2014.07.014_bib49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.emc.2014.07.014_bib50","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc8872","article-title":"Sepsis biomarkers: a review","volume":"14","author":"Pierrakos","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.emc.2014.07.014_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/eri.13.9","article-title":"Diagnostic and prognostic markers in sepsis","volume":"11","author":"Vincent","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.emc.2014.07.014_bib52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1586\/ers.12.6","article-title":"Biomarkers in community-acquired pneumonia","volume":"6","author":"Kruger","year":"2012","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.emc.2014.07.014_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/ers.13.6","article-title":"Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies","volume":"7","author":"Haubitz","year":"2013","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.emc.2014.07.014_bib54","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1097\/01.CCM.0000226413.54364.36","article-title":"Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis","volume":"34","author":"Uzzan","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(07)70052-X","article-title":"Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis","volume":"7","author":"Tang","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.emc.2014.07.014_bib56","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","article-title":"Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis","volume":"13","author":"Wacker","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.emc.2014.07.014_bib57","series-title":"Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: direction for a new program","first-page":"55","year":"1990"},{"key":"10.1016\/j.emc.2014.07.014_bib58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-133-4-200008150-00102","article-title":"The effect of clinical practice guidelines on variations in care","volume":"133","author":"Gundersen","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.emc.2014.07.014_bib59","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving Sepsis Campaign guidelines for the management of severe sepsis and septic shock","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib60","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib61","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s00134-010-1786-8","article-title":"A\u00a0critical appraisal of the quality of critical care clinical practice guidelines and their strength of recommendations","volume":"36","author":"Gorman","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.emc.2014.07.014_bib62","doi-asserted-by":"crossref","first-page":"R266","DOI":"10.1186\/cc13096","article-title":"Clinical stakeholders\u2019 opinions on the use of selective decontamination of the digestive tract in critically ill patients in intensive care units: an international Delphi study","volume":"17","author":"Cuthbertson","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.emc.2014.07.014_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.annemergmed.2013.08.004","article-title":"The surviving sepsis campaign guidelines 2012: update for emergency physicians","volume":"63","author":"Jones","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2014.07.014_bib64","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.emc.2014.07.014_bib65","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2146\/ajhp090026","article-title":"ASHP guidelines on managing drug product shortages in hospitals and health systems","volume":"66","author":"Fox","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.emc.2014.07.014_bib66","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/cid\/cir954","article-title":"The impact of anti-infective drug shortages on hospitals in the United States: trends and causes","volume":"54","author":"Griffith","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.emc.2014.07.014_bib67","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12630-013-9920-z","article-title":"Drug shortages in Canadian anesthesia: a national survey","volume":"60","author":"Hall","year":"2013","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.emc.2014.07.014_bib68","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.2146\/ajhp110210","article-title":"Impact of drug shortages on U.S. health systems","volume":"68","author":"Kaakeh","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.emc.2014.07.014_bib69","unstructured":"American Society of Health-System Pharmacists (ASHP). Drug Shortages Resource Center. Available at: http:\/\/www.ashp.org\/drugshortages\/current. Accessed November 24, 2013."},{"key":"10.1016\/j.emc.2014.07.014_bib70","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/666332","article-title":"Prospective approach to managing antimicrobial drug shortages","volume":"33","author":"Griffith","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.emc.2014.07.014_bib71","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/j.1875-9114.2012.01158.x","article-title":"Antimicrobial drug shortages: a crisis amidst the epidemic and the need for antimicrobial stewardship efforts to lessen the effects","volume":"32","author":"Griffith","year":"2012","journal-title":"Pharmacotherapy"}],"container-title":["Emergency Medicine Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862714000698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862714000698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T21:46:05Z","timestamp":1565819165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733862714000698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0733862714000698"],"URL":"https:\/\/doi.org\/10.1016\/j.emc.2014.07.014","relation":{},"ISSN":["0733-8627"],"issn-type":[{"value":"0733-8627","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency Department Antimicrobial Considerations in Severe Sepsis","name":"articletitle","label":"Article Title"},{"value":"Emergency Medicine Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.emc.2014.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}